Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
2
40%
Ph phase_1
1
20%
Ph early_phase_1
1
20%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(1)
Terminated(2)
Other(1)

Detailed Status

Enrolling by invitation1
Terminated1
Withdrawn1
unknown1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
50.0%
Most Advanced
Phase 1

Trials by Phase

Early Phase 11 (25.0%)
Phase 11 (25.0%)
N/A2 (50.0%)

Trials by Status

enrolling_by_invitation120%
terminated120%
withdrawn120%
unknown120%
completed120%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
DEVICE
Total Trials
5